Press "Enter" to skip to content

Mylan gets FDA warning letter over infractions at West Virginia plant

Mylan NV said on Tuesday it is addressing issues raised in a warning letter it received earlier this month from the U.S. Food and Drug Administration, which flagged concerns regarding the drugmaker’s manufacturing plant in West Virginia.

Original source:

Also Read:   Common nerve pain drug linked to suicidal behavior, overdose